Home › Dermatitis › California
Dermatitis clinical trials in California
6 studies for Dermatitis are looking for participants at sites in California.
Cities in California
A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
- Kern Research, Inc., Bakersfield
- First OC Dermatology Research Inc, Fountain Valley
- Northridge Clinical Trials, Northridge
- and 2 more
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Nov 12, 2026 · NCT07765888First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
- Alliance Clinical, Focus Clinical Research, West Hills
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 65 · All sexes · Updated Nov 6, 2026 · NCT07527923A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema
- Kern Research, Inc., Bakersfield
- First OC Dermatology Research Inc, Fountain Valley
- Marvel Clinical Research, Huntington Beach
- and 4 more
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Nov 6, 2026 · NCT07783425Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
- Novartis Investigative Site, Fountain Valley
- Novartis Investigative Site, Los Angeles
- Novartis Investigative Site, Sacramento
- and 2 more
RecruitingPhase 2
Ages 18 to 100 · All sexes · Updated Sep 28, 2026 · NCT06947993A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- Marvel Research, LLC, Huntington Beach
- Metropolis Dermatology, Los Angeles
- Dermatology Research Associates, Los Angeles
- and 4 more
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Aug 28, 2026 · NCT07599813A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Inmagene Site 1, Lancaster
- Inmagene Site 23, Los Angeles
RecruitingPhase 2
Ages 18 to 74 · All sexes · Updated Aug 12, 2026 · NCT07037901From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.